Subscribe to our Newsletters !!

    Kumar Jeetendra

    Aster RV Hospital Launches Aster Breast Clinic with World Class Facilities

    Bangalore, 04 November 2020: Aster RV Hospital, a multi-specialty quaternary care hospital in Bengaluru, launched the Aster RV Breast Clinic in the city ahead of National Cancer Awareness Day. A dedicated center for women, the exclusive Breast Clinic will be led by a team of specialized doctors with vast experience in breast disorders and breast

    AstraZeneca expects COVID-19 immunization information this year

    AstraZeneca, the British drugmaker working on one of the world’s leading COVID-19 vaccine candidates, conquer third-quarter sales estimates on Thursday and reiterated it expects data from late-stage trials of the vaccine later this year. The business has taken on the development of Oxford University’s potential COVID-19 vaccine, scoring billions in funding and signing multiple prices

    Australia arranges more COVID-19 antibodies for absolute of 135 million portions

    AstraZeneca, the British drugmaker working on a few of the world’s leading COVID-19 vaccine candidates, conquer third-quarter sales estimates on Thursday and revealed it expects data from late-stage trials of the vaccine later this year. The business has taken on the evolution of Oxford University’s potential COVID-19 vaccine, scoring billions in financing and signing multiple

    ENPICOM services Neogene Therapeutics with its T cell repertoire sequencing data handling and analysis solution

    ‘s-Hertogenbosch, The Netherlands – November 5, 2020 – Life Science Newswire – ENPICOM B.V., an innovative bioinformatics software engineering company delivering ground-breaking products and customized solutions to decode the immune system and improve human health, today announced the company has entered into a service agreement with Neogene Therapeutics to grant the company access to ENPICOM’s

    WHO-drove COVID-19 medication plot copies down on antibodies, steroids and disregards remdesivir

    A World Health Organization-led scheme to provide COVID-19 drugs to poor countries is gambling on experimental monoclonal antibody treatments and steroids but is shunning Gilead’s remdesivir blockbuster therapy, an internal document shows. The WHO draft document, seen by Reuters and dated October 30, states the priorities are to secure monoclonal antibodies in a tight market

    Aster Labs introduces US FDA approved digital pathology solution

    Bangalore, November 06, 2020 – Aster Labs, the diagnostics arm of Aster DM Healthcare, a leading healthcare service provider in the country, has introduced US FDA approved digital pathology solution by Philips Intellisite Pathology Solutions for primary diagnosis at its state of the art reference lab located at Queens Road in Bangalore and at Aster

    Ultra-compact laboratory chiller without refrigerants :ultra-compact laboratory chiller without refrigerants

    Ultra-compact, easy to handle and versatile – the new Piccolo chiller convinces entirely with state-of-the-art thermoelectric Peltier technology. This technology enables accurate and rapid heating or cooling, entirely without refrigerant, which is a clear benefit for the environment. Furthermore this model is maintenance-free. With working temperatures of 4 to 70 °C and cooling capacities up

    Custom Rabbit & Mouse Recombinant Monoclonal Antibodies

    AMSBIO announce a new rabbit and mouse recombinant monoclonal antibody development service based upon a revolutionary technology platform. The DimAb™ development platform is different from traditional hybridoma fusion technologies in that it can directly isolate IgG genes from B cells of immunized animals. Using this novel platform – a number of custom development projects have

    BioMed X Institute Announces Expansion of their Strategic Collaboration with Janssen in Immunology Research

    HEIDELBERG, Germany, November 09, 2020 / B3C newswire / — German independent research institute BioMed X adds a further research program in the field of immunology to their existing collaboration with Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson: The new project will focus on the development of